title: Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge.
abstract: A controlled trial was performed to compare enteral feeding with either an amino acid based feed or a whole protein feed as sole treatment for active Crohn's disease. Twenty four patients were studied (nine with ileal, 11 with ileocolonic, and four with colonic disease). Both feeds proved effective; nine of 13 patients randomised to receive the amino acid based feed were in clinical remission within three weeks as defined by a simple activity index compared with eight of 11 treated with the whole protein feed. Patients in clinical remission were then crossed over onto the other feed. None of the six patients who were changed to the whole protein feed relapsed over the subsequent three week period compared with three of seven patients who were changed to the amino acid based feed. In responders the median serum C reactive protein concentration fell from 21 mg/l (range 9-82) on entry to 6 mg/l (range 3-19) at six weeks. Seven patients relapsed within eight months of starting solid food (mean 3.7 months), while nine were still in remission (follow up period 3-9 months, median six months). Detailed studies of staged reintroduction of food and permitted food additives were carried out over a four year period in a patient with extensive stricturing small bowel Crohn's disease who had been brought into remission by open treatment with enteral feeding. Carrageenan, other permitted emulsifiers, bread, meat, potatoes, oranges, refined sugar, dairy produce, flour, and rice were all reintroduced without any objective ill effect, but green vegetables provoked a clinical and biochemical relapse within one week of introduction. Remission was rapidly achieved by switching back to the enteral feed but reintroduction of the low residue diet that had been previously tolerated produced a brisk relapse. Clinical and biochemical remission was again achieved by a return to the enteral feed but relapse again occurred with reintroduction of the low residue diet. These studies confirm the therapeutic effect of enteral feeding in Crohn's disease. This effect does not seem to be due to avoidance of whole protein, but the very low residue of chemically defined enteral feeds may be important, particularly in patients with intestinal strictures.
authors.affiliation: University Department of Medicine, Walton Hospital, Liverpool.
authors.forename: A H
authors.initials: AH
authors.lastname: Raouf
authors.forename: V
authors.initials: V
authors.lastname: Hildrey
authors.forename: J
authors.initials: J
authors.lastname: Daniel
authors.forename: R J
authors.initials: RJ
authors.lastname: Walker
authors.forename: N
authors.initials: N
authors.lastname: Krasner
authors.forename: E
authors.initials: E
authors.lastname: Elias
authors.forename: J M
authors.initials: JM
authors.lastname: Rhodes
mesh_terms: D000328:Adult; D000596:Amino Acids / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000378:metabolism; D003424:Crohn Disease / Q000097:blood / Q000473:pathology / Q000628:therapy*; D004044:Dietary Proteins / Q000627:therapeutic use*; D004750:Enteral Nutrition; D006801:Humans; D007421:Intestine, Small / Q000473:pathology; D008297:Male
chemical_list: D000596:Amino Acids; D004044:Dietary Proteins; D002097:C-Reactive Protein